UBS Evidence Lab data that tracks iPhone availability across 30 geographies suggests wait times continue to track flat to lower week over week on average across the lineup, the firm’s analyst tells investors in a research note. The firm notes that the Pro and Pro Max in the U.S. each ticked higher week over week, and wait times for the Pro Max are elevated by ~6 days year over year across the board. UBS has a Neutral rating and $220 price target on Apple (AAPL) shares.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AAPL:
- Apple price target raised to $320 from $270 at BofA
- Apple (AAPL) Is About to Report Q4 Earnings Tomorrow. Here Is What to Expect
- MSFT vs. GOOGL: Which ‘Magnificent 7’ AI Stock Will Impress Wall Street This Earnings Season?
- Is Apple Stock (AAPL) a Buy Ahead of Earnings?
- Apple preparing screen upgrades for MacBook, iPad products, Bloomberg reports